DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nimustine
Nimustine
Relevance Network Between Chemosensitivity and Transcriptome in Human Hepatoma Cells1
Title Second-Line Chemotherapy for Small-Cell Lung Cancer
Nimustine Induces DNA Breaks and Crosslinks in NIH/3T3 Cells
Nanoconjugates Able to Cross the Blood-Brain Barrier Alexander H Stegh, Janina Paula Luciano, Samuel A
II. Recurring Tumors
Review Article
E-Table 1. Drug Classification Category Name Generic Name
Ep 3067054 A1
Current Challenges and Opportunities in Treating Glioblastomas
EANO Guidelines on the Diagnosis and Treatment of Diffuse Gliomas of Adulthood
Development of Newly Synthesized Chromone Derivatives with High Tumor Specificity Against Human Oral Squamous Cell Carcinoma
Promising Survival for Patients with Glioblastoma Multiforme Treated with Individualised Chemotherapy Based on in Vitro Drug Sensitivity Testing
Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels To
Liste Des Molécules
FIGURE 1 Human Subjects with Bispecific Anti-CD 123 X Anti-CD3 Antibodies
United States Patent (19) 11 Patent Number: 5,728,680 Morozov Et Al
Supplement 1A. Antineoplastic Medications Samples of the Intervention Group
WO 2010/091198 Al
Top View
List of Cancer Drugs (The First Batch) Ⅰ.Cancer Drugs
Induction of Oxidative Stress by Anticancer Drugs in the Presence and Absence of Cells
Handling Cytostatic Drugs: Contents
Nimustine Hydrochloride (Rinnm) C12H10F3N3O4 = 317.2
From Old Alkylating Agents to New Minor Groove Binders
Clinical Study : Phase II Study of Continuous ACNU (Nimustine) And
Liste Des Molécules
Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma
Phenytoin Reduces 5-Ala Mediated Fluorescence in Glioblastoma Cells
Molecular Targeting Chemotherany for Glioblastoma
Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
3.1 Basic Principles of Chemotherapy
Impact of ROS Generated by Chemical, Physical, and Plasma Techniques on Cancer Attenuation
Molecular Blueprints for Antitumor Drugs
(12) Patent Application Publication (10) Pub. No.: US 2012/0077820 A1 Danter Et Al
What Is the Advance of Extent of Resection in Glioblastoma Surgical Treatment—A Systematic Review
(12) Patent Application Publication (10) Pub. No.: US 2007/0213382 A1 Rudy Et Al
Modified Conditioning Regimen with Idarubicin Followed by Autologous
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Association Between Acute Myelogenous Leukemia and Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia
Tan Tanta Cu O La Da Im Un Da Hata Kama
Can In-Vitro Chemoresponse Assays Help Find New Treatment
Insights from Pre-Clinical Studies for New Combination Treatment
Selected Alkylating Agents Can Overcome Drug Tolerance of G0-Like Tumor Cells And
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Ep 3348266 A1
ICD-10-CM Table of Drugs 2019
Selected Alkylating Agents Can Overcome Drug Tolerance of G0-Like Tumor Cells And
Can In-Vitro Chemoresponse Assays Help Find New Treatment
Brain Metastases in Breast Cancer – an in Vitro Study to Evaluate New Systemic Chemotherapeutic Options
Title Second-Line Chemotherapy for Small-Cell Lung Cancer (SCLC)
WO 2017/035116 Al O
Case Report Parotid Gland and Cerebellum Metastasis of Lung Cancer: a Case Report
Supplementary Figure 1: Prisma Flow Diagram Depicting Citations Identified, Screened and Included in the Comprehensive Literature Review